abstract |
Disclosed are compositions for the treatment of cancer comprising decitabine and tetrahydrouridine or 5-azacytidine and tetrahydrouridine. These compositions in the form of pills are administered to human subjects continuously or alternately, guided by the measurement of predictive biomarkers. [Selection figure] None |